View drug registration information details.


ItemsRegistration information
ID170
No170
Brand NameLANZAAR 50
IngredientsLOSARTAN POTASSIUM 50 MG
Dosage FormFILM-COATED TABLETS
Primary PackagingALU-PVDC BLISTERPACK
StorageSTORE BELOW 30'C,
Shelf Life2 YEARS AFTER MANUFACTURE
Pack Size3 X 10'S /BOX
Dispensing CategoryPrescription only
ATC ClassificationC09CA01
Pharmaceutical ClassHYPERTENSION
IndicationsTREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION. STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY
Contraindications- HYPERSENSITIVITY TO OTHER ANGIOTENSIN II RECEPTOR ANTAGONISTS - BILATERAL RENAL ARTERY STENOSIS - PREGNANCY ( 2 ND AND 3RD TRIMESTERS)
Side Effects> 10% : CHEST PAIN, FATIGUE, HYPOGLYCEMIA, DIARRHEA, URINARY TRACT INFECTION, ANEMIA, WEAKNESS, BACK PAIN, COUGH 1% TO 10%
Unit Price-
EDL No
DescriptionWHITE OVAL BICONVEX FILM COATED TABLETS WITH ''BERLIN'' ON ONE SIDE AND SCORED BETWEEN "L" AND "50" ON THE OTHER SIDE
Note
License OwnerBERLIN PHARMA LAO CO.,LTD
ManufacturerBERLIN PHARMACEUTICAL INDUSTRY CO., LTD.
CountryTHAILAND
Import Registration No1A 20/53 ( NG)
Import Registration Date2010-07-23
ActivityCERTIFICATE RELEASED
Applied Date2022-07-08
FDD Registration No03 I 3710/12
FDD Registration Date2022-09-14
Expiry Date2025-09-13

Back to drug list